NEW YORK (360Dx) – Sekisui Diagnostics said today that the US Food and Drug Administration has cleared the company's Sekure HbA1c assay as an aid in the diagnosis of diabetes mellitus.
It also has been cleared to aid in identifying patients at risk of developing diabetes mellitus and for the monitoring of long-term blood glucose control of patients with the condition.